A study of antibodies from SARSCoV2 Beta variant-infected patients revealed that while some antibodies bind both Beta & wild-type virus, others are Beta-specific. The results emphasize the antigenic complexity defining antibody immunity against SARS-CoV-2
We thank all study participants who devoted samples and time to our research, Dr. Kim Stahlberg and Meilan Zuo for patient recruitment, Stefanie Bandura, Matthias Sillmann, Doreen Brandl, Patricia Tscheak, and Sabine Engl for excellent technical assistance, and Dr. Marcel A. Müller and Dr. Daniela Niemeyer for support with BSL3 work. We acknowledge BIAFFIN GmbH & Co.
. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesPreclinical experiments in human cells and mice suggest CBD may prevent the replication of SARSCoV2, but the authors advise caution until completion of a clinical trial, citing questions on dosage, formulation, and mode of delivery. ScienceAdvances
Read more »
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesPreclinical experiments in human cells and mice suggest CBD may prevent the replication of SARSCoV2, but the authors advise caution until completion of a clinical trial, citing questions on dosage, formulation, and mode of delivery. ScienceAdvances
Read more »
Even Mild Covid-19 Can Cause Brain Dysfunction And Cognitive IssuesThe research provides new clues as to why some people with long Covid experience long-term cognitive issues after being infected with the SARS-CoV-2 coronavirus.
Read more »
Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Read more »
Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Read more »
FDA Curbs Use of COVID-19 Antibody Drugs Sidelined by OmicronU.S. health officials say COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant.
Read more »